SAFETY OPERATIONSSTANDARD

Evidence for safer work and accountable operations.

Chemical Risk · Official draft-risk-evaluation analysis

EPA's draft trans-1,2-dichloroethylene review is not final

EPA released a draft TSCA risk evaluation for trans-1,2-dichloroethylene and opened a 60-day comment period. The draft identifies significant contributions to unreasonable risk for workers and occupational non-users under 19 conditions of use and preliminarily identifies one consumer use, but EPA says the findings may change and current protections remain in place while the review continues.

Editorial figure by Safety Operations Standard. Source context: EPA draft trans-1,2-dichloroethylene risk evaluation.

Keep the draft finding in the right regulatory state

The direct answer is that EPA's release is a draft risk evaluation, not a final determination and not a new workplace requirement. A regulatory-change record should retain the source, chemical identity, TSCA stage, draft status, release and review dates, docket, comment period, peer-review milestone, conditions of use, populations, exposure pathways, preliminary findings, uncertainties, accountable owner, and next decision trigger.

Risk evaluation and risk management are related but different stages. A team can review the draft and its own chemical uses now without inventing a future rule. Any later final risk evaluation, proposed risk-management rule, final rule, effective date, compliance date, exemption, or judicial change should enter as a new dated event with its own scope and authority.

Map conditions of use before mapping controls

EPA's summary identifies occupational inhalation findings under 19 conditions of use and one preliminary consumer-use finding. An employer still needs to determine whether and where trans-1,2-dichloroethylene appears in its operations, mixtures, products, raw materials, cleaning or degreasing work, maintenance, laboratories, recycling, waste, supplier records, and contractor activity. Chemical name alone does not establish a site's condition of use or exposure scenario.

The evidence record should distinguish substance identity and concentration, supplier and safety-data-sheet version, quantity, process, task, frequency and duration, temperature and ventilation, open or closed handling, workers and occupational non-users, route of exposure, industrial-hygiene data, method and detection limit, personal protective equipment, engineering and administrative controls, waste path, and known gaps. It should also preserve why a condition of use was included, excluded, or unresolved.

Do not pause current protections while the review proceeds

EPA states that current protections remain in place. The draft should not be used to weaken an existing hazard assessment, exposure limit, ventilation control, respiratory-protection program, training, labeling, spill response, medical or industrial-hygiene practice, waste control, permit condition, or other applicable duty. Nor should a software flag imply that the organization has completed a qualified exposure assessment.

Owners can use the comment period to reconcile process knowledge with the draft, identify missing or conflicting exposure evidence, review the underlying methods, coordinate qualified industrial-hygiene and legal analysis, and submit supported comments when appropriate. Every interim action should state whether it follows an existing requirement, company policy, a qualified risk decision, or precautionary management rather than the draft's legal force.

Test an unresolved mixture and changing draft

A representative evaluation should load two materials with different trans-1,2-dichloroethylene concentrations, leave one supplier record incomplete, map tasks to workers and occupational non-users, attach sampling with a method limitation, preserve existing controls, prepare a draft-based scenario, and then revise a preliminary finding. Reviewers should identify each applicable and unresolved condition of use, distinguish current duties from analysis, retain the source version, and prevent a changed draft or later final action from rewriting past decisions.

EPA's official release supports the described draft status, preliminary scope, 19 occupational conditions of use, consumer-use finding, general-population and environmental statement, current-protection boundary, 60-day comment period, and peer-review process. It does not establish a site's chemical identity, use, exposure, control sufficiency, compliance, risk determination, or future regulatory requirement. Employers retain responsibility for chemical safety, industrial hygiene, worker protection, environmental management, regulatory compliance, and legal judgment.

Enterprise buyer test

Translate this change into the exact population, record type, workflow stage, decision owner, effective date, and evidence that could be affected. Ask current or prospective providers to demonstrate the named workflow with representative data and an exception—not a polished feature tour. Record what official documentation establishes, what a provider states, what the team observes, and what remains unresolved.

A defensible review also identifies the dependency outside the product. Authority interpretation, policy configuration, data quality, integrations, human judgment, approval rights, release governance, training, and retained evidence may remain customer or service responsibilities. The evaluation should preserve those boundaries instead of treating a technology claim as the complete operating model.

What we will watch next

Safety Operations Standard will watch the named source and affected market records for later evidence that changes status, scope, availability, implementation timing, workflow consequence, or the limits of the initial report. A later announcement does not silently overwrite this dated account; the change ledger preserves the sequence.

Primary source: EPA draft trans-1,2-dichloroethylene risk evaluation · Official EPA draft-risk-evaluation release.

Evidence boundary: This article independently analyzes EPA's official draft-risk-evaluation release reviewed August 29, 2026. EPA did not review or sponsor it, and no chemical identity, mixture, site, condition of use, worker population, exposure, sample, control, compliance duty, or outcome was tested. It is not occupational-safety, industrial-hygiene, environmental, medical, regulatory, compliance, or legal advice and does not establish exposure, risk, or a new requirement.

Editorial record: Published August 29, 2026; updated August 29, 2026. Corrections policy.